drugset / Trial / NCT00004036
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer
Supportive care
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumors from dividing so they stop growing or die. Chemoprotective drugs, such as amifostine, may protect normal cells from the side effects of chemotherapy. PURPOSE: Phase I trial to study the effectiveness of amifostine plus combination chemotherapy in treating patients with advanced cancer.
Timeline
- Start
- 1997-11
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | — | — |
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | amifostine | Unknown | — | Intravenous |
| Subject | sargramostim | Protein / enzyme biologic | — | Subcutaneous |